Patents / Licensing / Technology Transfer

Nanoparticles incorporated self-gelling composition as drug delivery system.

Micronutrient supplement lip-salve.

In-situ depot release therapy for regenerative medicines

Publications :

Discover our latest research publications and articles.

December 2024

Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy.
Nanoscale. 2024;16(13):6330-6364. doi:10.1039/d3nr06131k

November 2023

Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model.
Drug Deliv Transl Res. 2023;13(2):608-626. doi:10.1007/s13346-022-01220-8
Insight into lipid-based nanoplatform-mediated drug and gene delivery in neuro-oncology and their clinical prospects.
Front Oncol. 2023;13:1168454. doi:10.3389/fonc.2023.1168454

October 2022

Bio-polymeric transferrin-targeted temozolomide nanoparticles in gel for post-surgical GBM therapy. Nanoscale, 2022;14(35):12773-12788. doi:10.1039/d2nr00171c
Spatial specific delivery of combinational chemotherapeutics to combat intratumoral heterogeneity.
J Control Release. 2022;348:1004-1015. doi:10.1016/j.jconrel.2022.06.046

October 2021

Non-invasive transferrin targeted nanovesicles sensitize resistant glioblastoma multiforme tumors and improve survival in orthotopic mouse models.
Nanoscale. 2021;14(1):108-126. doi:10.1039/d1nr05460k

August 2018

Stable Liposome in Cosmetic Platforms for Transdermal Folic acid delivery for fortification and treatment of micronutrient deficiencies.
Sci Rep. 2018;8(1):16122. doi:10.1038/s41598-018-34205-0
Nanotechnology-based strategies as novel therapies in gliomas.
Ther Deliv. 2018;9(8):571-592. doi:10.4155/tde-2018-0022
Advances in point-of-care diagnostic devices in cancers.
Analyst. 2018;143(6):1326-1348. doi:10.1039/c7an01771e